Kardegic and blood thyroid stimulating hormone decreased Patient Reports February 10, 2010

Kardegic Side Effects Report #5243525-1
Kardegic side effect was reported by a Consumer or non-health professional from FRANCE on Feb 19, 2007. Male patient, 83 years of age, was diagnosed with cardiomyopathy , brain neoplasm, hypertension and was treated with Kardegic. After drug was administered, patient experienced the following side effects: blood thyroid stimulating hormone decreased, cardiomyopathy , dysphagia, gastrointestinal tube insertion, haemangioma, hyperthyroidism, iodine uptake increased, thyroid neoplasm. Kardegic dosage: unknown. During the same period patient was treated with OMEPRAZOLE, TEMGESIC, MICARDIS, HEMIGOXINE NATIVELLE, NITRODERM, NEO MERCAZOLE. Patient was hospitalized. Patient died on 06/23/2006.

Kardegic Side Effects Report #5247859-6
Kardegic side effect was reported by a Consumer or non-health professional from FRANCE on Feb 19, 2007. Male patient, 83 years of age, was diagnosed with cardiomyopathy , brain neoplasm, hypertension and was treated with Kardegic. After drug was administered, patient experienced the following side effects: blood thyroid stimulating hormone decreased, cardiomyopathy , dysphagia, gastrointestinal tube insertion, haemangioma, hyperthyroidism, iodine uptake increased, thyroid neoplasm. Kardegic dosage: unknown. During the same period patient was treated with OMEPRAZOLE, TEMGESIC, MICARDIS, HEMIGOXINE NATIVELLE, NITRODERM, NEO MERCAZOLE. Patient was hospitalized. Patient died on 06/23/2006.